Why the study?
Do ACE inhibitors improve left ventricular morphology and function more than calcium antagonists in patients with essential hypertension and LVH?
Do ACE inhibitors improve left ventricular morphology and function more than calcium antagonists in patients with essential hypertension and LVH?
In patients with essential hypertension and LVH, ACE inhibitors improve left ventricular systolic and diastolic function more than calcium antagonists, despite similar reductions in blood pressure and LV mass.
Answers are grounded in this paper and cite their sources.
ACE inhibitors may confer greater LV functional benefits than calcium antagonists in hypertensive LVH; hypothesis-generating and requires randomized confirmation.
We compared the effects of two long-term antihypertensive treatments (ACE inhibitors vs. Ca antagonists) on left ventricular hypertrophy (LVH) and LV function in patients with essential hypertension and LVH. After a washout period of at least 4 wk, ceronapril or delapril was administered to 18 patients and nifedipine or nicardipine to 15 patients for 6 months. Mean blood pressure (MBP), LV mass (LVM), LV fractional shortening (FS), systolic time intervals (ejection time/pre-ejection period ratio = ET/PEP), and isovolumic relaxation time (IRT) were examined in the pretreatment phase and after 6 months of treatment. MBP and LVM significantly and similarly decreased after treatment in both groups (ACE inhibitors vs. Ca antagonists, delta MBP: -17.1 +/- 1.3 vs. -16.9 +/- 1.6%; delta LVM: -11.7 +/- 2.7 vs. -10.0 +/- 3.8%, both p = not significant). ACE inhibitors produced significant beneficial changes in FS, ET/PEP, and IRT after treatment as compared with Ca antagonists (ACE inhibitors vs. Ca antagonists, delta FS: 11.8 +/- 3.3 vs. 5.1 +/- 4.1%, p < 0.05; delta ET/PEP: 11.9 +/- 2.3 vs. 4.7 +/- 6.4%, p < 0.05; delta IRT: -12.0 +/- 3.4 vs. -3.8 +/- 6.1%, p < 0.05). The results indicate that both ACE inhibitors and Ca antagonists induce significant and similar reductions in blood pressure and LVM in hypertensive patients. ACE inhibitors produce significant improvements in LV function in both systolic and diastolic phases as compared with Ca antagonists.
No takes yet. Share an insight, caveat, or question.
Matsuzaki et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: